The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA4207003
Max Phase: Preclinical
Molecular Formula: C19H14N4O2S
Molecular Weight: 362.41
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: O=C1CS/C(=N/N=C\c2c[nH]c3ccccc23)N1C(=O)c1ccccc1
Standard InChI: InChI=1S/C19H14N4O2S/c24-17-12-26-19(23(17)18(25)13-6-2-1-3-7-13)22-21-11-14-10-20-16-9-5-4-8-15(14)16/h1-11,20H,12H2/b21-11-,22-19+
Standard InChI Key: PLVTYICQGWZMSM-VDXQQSIMSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 362.41Molecular Weight (Monoisotopic): 362.0837AlogP: 3.27#Rotatable Bonds: 3Polar Surface Area: 77.89Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0CX Acidic pKa: 13.23CX Basic pKa: CX LogP: 3.42CX LogD: 3.42Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.44Np Likeness Score: -1.01
References 1. Carradori S, Bizzarri B, D'Ascenzio M, De Monte C, Grande R, Rivanera D, Zicari A, Mari E, Sabatino M, Patsilinakos A, Ragno R, Secci D.. (2017) Synthesis, biological evaluation and quantitative structure-active relationships of 1,3-thiazolidin-4-one derivatives. A promising chemical scaffold endowed with high antifungal potency and low cytotoxicity., 140 [PMID:28963991 ] [10.1016/j.ejmech.2017.09.026 ]